Moleculin Biotech, Inc. (MBRX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 10.96M | 9.69M | 7.88M | 9.08M | 9.34M | 5.19M | 11.61M | 13.73M | 18.96M | 26.27M | 27.6M | 35.38M | 39.29M | 45.6M | 53.49M | 61.32M | 67.26M | 72.5M | 77.07M | 81.84M |
| Cash & Short-Term Investments | 10.32M | 8.88M | 6.7M | 7.56M | 7.72M | 4.28M | 9.4M | 10.85M | 16.82M | 23.55M | 24.58M | 32.17M | 37.27M | 43.15M | 50.39M | 58M | 66.1M | 70.9M | 75.18M | 79.51M |
| Cash Only | 10.32M | 8.88M | 6.7M | 7.56M | 7.72M | 4.28M | 9.4M | 10.85M | 16.82M | 23.55M | 24.58M | 32.17M | 37.27M | 43.15M | 50.39M | 58M | 66.1M | 70.9M | 75.18M | 79.51M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 7K | 6K | 5K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 12K | 0 | 0 | 0 | 0 | 0 | 45K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 644K | 801K | 367K | 411K | 1.32M | 351K | 0 | 466K | 0 | 644K | 0 | 903K | 2.02M | 823K | 817K | 937K | 584K | 486K | 1.89M | 2.33M |
| Total Non-Current Assets | 12.4M | 12.44M | 12.47M | 12.52M | 11.67M | 11.73M | 11.79M | 11.84M | 11.89M | 11.94M | 11.92M | 11.73M | 11.77M | 11.83M | 11.88M | 11.93M | 11.54M | 11.59M | 11.63M | 11.7M |
| Property, Plant & Equipment | 284K | 314K | 420K | 469K | 525K | 583K | 640K | 696K | 740K | 796K | 772K | 587K | 625K | 678K | 731K | 785K | 393K | 445K | 484K | 550K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K |
| Other Non-Current Assets | 970K | 978K | 900K | 900K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 395K |
| Total Assets | 23.36M | 22.13M | 20.35M | 21.59M | 21.01M | 16.93M | 23.39M | 25.57M | 30.84M | 38.22M | 39.52M | 47.12M | 51.06M | 57.42M | 65.37M | 73.25M | 78.8M | 84.09M | 88.7M | 93.53M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 11.18% | 30.73% | -13% | -15.57% | -31.88% | -55.71% | -40.81% | -45.72% | -39.59% | -33.45% | -39.54% | -35.68% | -35.2% | -31.71% | -26.3% | -21.68% | -21.03% | 189.66% | 226.78% | 198.07% |
| Total Current Liabilities | 7.96M | 6.85M | 5.68M | 7.91M | 6.9M | 5.36M | 5.59M | 5.75M | 5.41M | 6.82M | 3.89M | 6.55M | 5.03M | 4.82M | 6.36M | 5.86M | 4.83M | 3.62M | 3.66M | 3.35M |
| Accounts Payable | 4.57M | 3.51M | 2.12M | 3.72M | 2.71M | 2.03M | 2.55M | 2.83M | 2.1M | 2.5M | 2.01M | 4.14M | 1.94M | 2.1M | 3.57M | 3.18M | 2.22M | 1.36M | 1.39M | 1.5M |
| Days Payables Outstanding | 45.46K | - | - | 10.08K | - | 6.8K | - | - | - | 5.92K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 137K | 132K | 128K | 124K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 96K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.39M | 3.21M | 2.08M | 2.39M | 2.06M | 0 | 0 | 0 | 0 | 0 | 0 | 2.42M | 0 | 0 | 0 | 0 | 0 | 1.56M | 1.8M | 1.61M |
| Current Ratio | 1.38x | 1.41x | 1.39x | 1.15x | 1.35x | 0.97x | 2.08x | 2.39x | 3.51x | 3.86x | 7.10x | 5.40x | 7.81x | 9.46x | 8.41x | 10.47x | 13.91x | 20.02x | 21.08x | 24.43x |
| Quick Ratio | 1.38x | 1.41x | 1.39x | 1.15x | 1.35x | 0.97x | 2.08x | 2.39x | 3.51x | 3.86x | 7.10x | 5.40x | 7.81x | 9.46x | 8.41x | 10.47x | 13.91x | 20.02x | 21.08x | 24.43x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 218K | 266K | 41.59M | 20.84M | 14.07M | 5.59M | 10.32M | 2.12M | 3.85M | 5.33M | 497K | 293K | 346K | 412K | 593K | 1.04M | 1.3M | 1.48M | 3.79M | 5.48M |
| Long-Term Debt | 185K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 222K | 258K | 292K | 326K | 358K | 390K | 420K | 450K | 474K | 496K | 291K | 308K | 335K | 365K | 388K | 50K | 63K | 75K | 94K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 33K | 44K | 41.33M | 20.55M | 13.75M | 5.23M | 9.93M | 1.7M | 3.4M | 4.86M | 1K | 2K | 38K | 77K | 228K | 649K | 1.25M | 1.41M | 3.71M | 5.39M |
| Total Liabilities | 8.18M | 7.12M | 47.27M | 28.76M | 20.97M | 10.95M | 15.91M | 7.87M | 9.26M | 12.14M | 4.38M | 6.85M | 5.38M | 5.23M | 6.96M | 6.9M | 6.14M | 5.1M | 7.44M | 8.83M |
| Total Debt | 185K | 359K | 390K | 420K | 450K | 478K | 506K | 532K | 559K | 574K | 584K | 291K | 308K | 451K | 477K | 486K | 127K | 159K | 190K | 220K |
| Net Debt | -10.13M | -8.52M | -6.31M | -7.14M | -7.27M | -3.8M | -8.9M | -10.31M | -16.27M | -22.98M | -24M | -31.88M | -36.96M | -42.69M | -49.91M | -57.51M | -65.98M | -70.74M | -74.99M | -79.29M |
| Debt / Equity | 0.01x | 0.02x | - | - | 10.71x | 0.08x | 0.07x | 0.03x | 0.03x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 15.18M | 15.01M | -26.92M | -7.17M | 42K | 5.98M | 7.48M | 17.7M | 21.59M | 26.07M | 35.14M | 40.27M | 45.68M | 52.19M | 58.42M | 66.36M | 72.67M | 78.99M | 81.26M | 84.7M |
| Equity Growth % | 36050% | 150.98% | -459.94% | -140.47% | -99.81% | -77.07% | -78.72% | -56.03% | -52.75% | -50.04% | -39.85% | -39.32% | -37.13% | -33.93% | -28.11% | -21.65% | -17.91% | 344.78% | 461.69% | 441.94% |
| Book Value per Share | 0.37 | 1.27 | -18.04 | -11.54 | 11.24 | 44.24 | 50.34 | 174.04 | 218.83 | 325.38 | 442.04 | 508.63 | 595.88 | 683.66 | 765.22 | 870.61 | 953.50 | 1036.53 | 1066.45 | 1116.37 |
| Total Shareholders' Equity | 15.18M | 15.01M | -26.92M | -7.17M | 42K | 5.98M | 7.48M | 17.7M | 21.59M | 26.07M | 35.14M | 40.27M | 45.68M | 52.19M | 58.42M | 66.36M | 72.67M | 78.99M | 81.26M | 84.7M |
| Common Stock | 5K | 3K | 49K | 30K | 14K | 3K | 3K | 3K | 2K | 33K | 30K | 30K | 30K | 29K | 29K | 29K | 29K | 29K | 29K | 29K |
| Retained Earnings | -218.85M | -206M | -221.56M | -167.44M | -159.8M | -153.37M | -151.49M | -140.89M | -136.57M | -131.6M | -121.33M | -115.73M | -109.75M | -101.83M | -95.06M | -86.45M | -79.68M | -72.81M | -69.98M | -65.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -52K | 10K | -44K | -38K | -38K | -41K | 4K | -10K | -18K | -9K | -3K | 7K | 8K | 12K | 3K | 22K | 53K | 41K | 39K | 55K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |